financetom
Business
financetom
/
Business
/
Titan Medical Amends Amalgamation Agreement with Conavi Medical; Pushes Back Annual General and Special Meeting
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Titan Medical Amends Amalgamation Agreement with Conavi Medical; Pushes Back Annual General and Special Meeting
May 29, 2024 5:57 AM

08:42 AM EDT, 05/29/2024 (MT Newswires) -- Titan Medical ( TMDIF ) on Wednesday said it amended the amalgamation agreement between Conavi Medical, 1000824255 Ontario Inc. (a Titan subsidiary) and Titan, for the merger of Conavi and Titan. The Toronto Stock Exchange has also granted Titan an extension to hold its Annual General and Special Meeting of Shareholders.

The amending agreement extends the outside date to complete the transaction to August 30, 2024. It also extends the date when the concurrent financing must be committed and Conavi financial statements must be completed to June 21.

Titan has also extended its AGM to a date on or before July 31. The extension will allow Titan and Conavi to finalize matters related to the transaction (which will require the approval of Titan's shareholders).

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Galapagos Says FDA Clears IND Application for Phase 1/2 Cancer Therapy Study
Galapagos Says FDA Clears IND Application for Phase 1/2 Cancer Therapy Study
Aug 29, 2024
07:00 AM EDT, 08/23/2024 (MT Newswires) -- Galapagos (GLPG) said the US Food and Drug Administration has approved an investigational new drug application for the study of its experimental therapy, GLPG5101, in patients with relapsed/refractory non-Hodgkin lymphoma. GLPG5101, produced using a decentralized cell therapy manufacturing platform, can potentially administer fresh, fit cells within a median vein-to-vein time of seven days....
Workday Shares Are Trading 12% Higher In Premarket Today: Here's Why
Workday Shares Are Trading 12% Higher In Premarket Today: Here's Why
Aug 29, 2024
The shares of Workday Inc. ( WDAY ) experienced a nearly 13% surge in pre-market trading on Friday. This significant increase is attributed to the company’s impressive second-quarter results and an encouraging long-term outlook. According to Benzinga Pro, at the time of writing, Workday was trading 12.51% higher at $259.99 after closing at $231.08 on Thursday. Workday’s second-quarter revenue amounted...
O3 Mining Files Prospectus Supplement for Public Offering of Units
O3 Mining Files Prospectus Supplement for Public Offering of Units
Aug 29, 2024
06:52 AM EDT, 08/23/2024 (MT Newswires) -- O3 Mining ( OIIIF ) on Friday said it filed a prospectus supplement to its short form base shelf prospectus for the sale of $18.2 million of units. The value can rise to as much as $20.9 million of units if the over-allotment option is exercised in full. Separately, the company said it...
Market Chatter: AstraZeneca Reportedly Warned UK Government of Moving Vaccine Production to US; Company Refutes Media Claims
Market Chatter: AstraZeneca Reportedly Warned UK Government of Moving Vaccine Production to US; Company Refutes Media Claims
Aug 29, 2024
07:05 AM EDT, 08/23/2024 (MT Newswires) -- AstraZeneca ( AZN ) refuted claims in a Financial Times report Thursday that it allegedly warned UK authorities of plans to relocate its Speke vaccine manufacturing site to Philadelphia due to stalled negotiations with the Labour government over reduced state aid promised to the project, a spokesperson told MT Newswires in an emailed...
Copyright 2023-2026 - www.financetom.com All Rights Reserved